Table of Content

1 Radiopharmaceutical Market Introduction and Overview
1.1 Radiopharmaceutical Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Revenue and Market Share by Manufacturer
2.2 Manufacturers Radiopharmaceutical Production Sites, Area Served, Product Types
2.3 Radiopharmaceutical Market Competitive Situation and Trends
2.3.1 Radiopharmaceutical Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Bayer
3.1.1 Bayer Company Profile
3.1.2 Radiopharmaceutical Product Overview
3.1.3 Bayer Radiopharmaceutical Market Performance (2019-2024)
3.1.4 Bayer Business Overview
3.2 Triad Isotopes
3.2.1 Triad Isotopes Company Profile
3.2.2 Radiopharmaceutical Product Overview
3.2.3 Triad Isotopes Radiopharmaceutical Market Performance (2019-2024)
3.2.4 Triad Isotopes Business Overview
3.3 Lantheus
3.3.1 Lantheus Company Profile
3.3.2 Radiopharmaceutical Product Overview
3.3.3 Lantheus Radiopharmaceutical Market Performance (2019-2024)
3.3.4 Lantheus Business Overview
3.4 GE Healthcare
3.4.1 GE Healthcare Company Profile
3.4.2 Radiopharmaceutical Product Overview
3.4.3 GE Healthcare Radiopharmaceutical Market Performance (2019-2024)
3.4.4 GE Healthcare Business Overview
3.5 Mallinckrodt
3.5.1 Mallinckrodt Company Profile
3.5.2 Radiopharmaceutical Product Overview
3.5.3 Mallinckrodt Radiopharmaceutical Market Performance (2019-2024)
3.5.4 Mallinckrodt Business Overview
3.6 Eli Lilly
3.6.1 Eli Lilly Company Profile
3.6.2 Radiopharmaceutical Product Overview
3.6.3 Eli Lilly Radiopharmaceutical Market Performance (2019-2024)
3.6.4 Eli Lilly Business Overview
3.7 Bracco Imaging
3.7.1 Bracco Imaging Company Profile
3.7.2 Radiopharmaceutical Product Overview
3.7.3 Bracco Imaging Radiopharmaceutical Market Performance (2019-2024)
3.7.4 Bracco Imaging Business Overview
3.8 SIEMENS
3.8.1 SIEMENS Company Profile
3.8.2 Radiopharmaceutical Product Overview
3.8.3 SIEMENS Radiopharmaceutical Market Performance (2019-2024)
3.8.4 SIEMENS Business Overview
3.9 Navidea
3.9.1 Navidea Company Profile
3.9.2 Radiopharmaceutical Product Overview
3.9.3 Navidea Radiopharmaceutical Market Performance (2019-2024)
3.9.4 Navidea Business Overview
3.10 Nordion
3.10.1 Nordion Company Profile
3.10.2 Radiopharmaceutical Product Overview
3.10.3 Nordion Radiopharmaceutical Market Performance (2019-2024)
3.10.4 Nordion Business Overview
3.11 IBA Group
3.11.1 IBA Group Company Profile
3.11.2 Radiopharmaceutical Product Overview
3.11.3 IBA Group Radiopharmaceutical Market Performance (2019-2024)
3.11.4 IBA Group Business Overview
3.12 Jubilant Pharma
3.12.1 Jubilant Pharma Company Profile
3.12.2 Radiopharmaceutical Product Overview
3.12.3 Jubilant Pharma Radiopharmaceutical Market Performance (2019-2024)
3.12.4 Jubilant Pharma Business Overview
4 Global Radiopharmaceutical Historical and Forecast Market Analysis by Type
4.1 Global Radiopharmaceutical Revenue and Market Share by Type
4.2 Global Radiopharmaceutical Revenue Market Forecast by Type (2024-2030)
5 Global Radiopharmaceutical Historical and Forecast Market Analysis by Application
5.1 Global Radiopharmaceutical Revenue Market Share by Application (2019-2024)
5.2 Radiopharmaceutical Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2 Radiopharmaceutical Growth Trends Analysis by Regions
6.2.1 Radiopharmaceutical Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Radiopharmaceutical Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Radiopharmaceutical Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.5 Europe Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.6 China Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.7 Japan Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.8 Korea Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.10 India Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.11 South America Radiopharmaceutical Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Radiopharmaceutical Market Size & Forecast (2019-2030)
7 North America
7.1 North America Radiopharmaceutical Revenue by Players
7.2 North America Radiopharmaceutical Revenue by Types
7.3 North America Radiopharmaceutical Revenue by Applications
7.4 North America Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Radiopharmaceutical Revenue by Players
8.2 Europe Radiopharmaceutical Revenue by Types
8.3 Europe Radiopharmaceutical Revenue by Applications
8.4 Europe Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Radiopharmaceutical Revenue by Players
9.2 China Radiopharmaceutical Revenue by Types
9.3 China Radiopharmaceutical Revenue by Applications
9.4 China Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Radiopharmaceutical Revenue by Players
10.2 Japan Radiopharmaceutical Revenue by Types
10.3 Japan Radiopharmaceutical Revenue by Applications
10.4 Japan Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Radiopharmaceutical Revenue by Players
11.2 Korea Radiopharmaceutical Revenue by Types
11.3 Korea Radiopharmaceutical Revenue by Applications
11.4 Korea Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Radiopharmaceutical Revenue by Players
12.2 Southeast Asia Radiopharmaceutical Revenue by Types
12.3 Southeast Asia Radiopharmaceutical Revenue by Applications
12.4 Southeast Asia Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Radiopharmaceutical Revenue by Players
13.2 India Radiopharmaceutical Revenue by Types
13.3 India Radiopharmaceutical Revenue by Applications
13.4 India Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Radiopharmaceutical Revenue by Players
14.2 South America Radiopharmaceutical Revenue by Types
14.3 South America Radiopharmaceutical Revenue by Applications
14.4 South America Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Radiopharmaceutical Revenue by Players
15.2 Middle East & Africa Radiopharmaceutical Revenue by Types
15.3 Middle East & Africa Radiopharmaceutical Revenue by Applications
15.4 Middle East & Africa Radiopharmaceutical Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Radiopharmaceutical Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Radiopharmaceutical Industrial Chain Analysis
17 Radiopharmaceutical Industry Dynamic Analysis
17.1 Radiopharmaceutical Market Trends Analysis
17.2 Radiopharmaceutical Market Drivers Analysis
17.3 Radiopharmaceutical Market Challenges Analysis
17.4 Radiopharmaceutical Market Restraints Analysis
18 Research Findings and Conclusion